Heart Failure Clinics

Scope & Guideline

Exploring New Frontiers in Heart Failure Management

Introduction

Explore the comprehensive scope of Heart Failure Clinics through our detailed guidelines, including its aims and scope. Stay updated with trending and emerging topics, and delve into declining areas to understand shifts in academic interest. Our guidelines also showcase highly cited topics, featuring influential research making a significant impact. Additionally, discover the latest published papers and those with high citation counts, offering a snapshot of current scholarly conversations. Use these guidelines to explore Heart Failure Clinics in depth and align your research initiatives with current academic trends.
LanguageEnglish
ISSN1551-7136
PublisherELSEVIER SCIENCE INC
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 2005 to 2024
AbbreviationHEART FAIL CLIN / Heart Fail. Clin.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressSTE 800, 230 PARK AVE, NEW YORK, NY 10169

Aims and Scopes

Heart Failure Clinics is dedicated to advancing the understanding, diagnosis, and management of heart failure through comprehensive research and clinical insights. The journal focuses on a multidisciplinary approach, integrating cardiology, imaging techniques, pharmacotherapy, and innovative technologies to address the complexities of heart failure.
  1. Heart Failure Pathophysiology and Management:
    Research articles delve into the underlying mechanisms of heart failure, providing insights into effective management strategies for various types, including heart failure with reduced and preserved ejection fraction.
  2. Innovative Therapeutic Approaches:
    The journal emphasizes novel treatments, including pharmacological interventions, mechanical circulatory support, and non-pharmacological approaches, highlighting their efficacy and safety in heart failure patients.
  3. Advanced Imaging Techniques:
    A significant focus is placed on the role of advanced imaging modalities, such as cardiovascular magnetic resonance and echocardiography, in diagnosing and managing heart failure.
  4. Emerging Technologies and Digital Health:
    The journal explores the integration of artificial intelligence, remote monitoring devices, and telehealth in improving heart failure care and patient outcomes.
  5. Special Populations and Comorbidities:
    Research often addresses heart failure in special populations, including patients with congenital heart disease, obesity, and cancer, as well as comorbid conditions that complicate management.
Recent publications in Heart Failure Clinics indicate a dynamic shift towards several emerging themes that reflect current challenges and advancements in heart failure management. These trends illustrate the journal's responsiveness to new knowledge and clinical needs.
  1. Role of Artificial Intelligence and Machine Learning:
    There is an increasing emphasis on utilizing AI and machine learning for predictive analytics, diagnostic imaging, and personalized treatment plans, reflecting a significant trend towards technological integration in clinical practice.
  2. Focus on Comorbidities and Multidisciplinary Care:
    Emerging themes highlight the importance of addressing comorbid conditions such as obesity, diabetes, and cancer in heart failure management, fostering a comprehensive approach to patient care.
  3. Health Disparities and Social Determinants:
    Recent publications are increasingly discussing racial, ethnic, and gender disparities in heart failure care, emphasizing the need for equitable healthcare strategies.
  4. Impact of COVID-19 on Heart Failure:
    The COVID-19 pandemic has generated a surge in research exploring its direct and indirect effects on heart failure patients, including complications and altered care pathways.
  5. Advancements in Mechanical Circulatory Support:
    Innovations in mechanical devices, including left ventricular assist devices, are receiving heightened attention, reflecting ongoing advancements in treatment options for advanced heart failure.

Declining or Waning

While Heart Failure Clinics has consistently explored a wide range of topics, certain themes appear to be declining in prominence over recent years. This shift may reflect evolving research interests or advancements in treatment methodologies.
  1. Traditional Pharmacotherapy Focus:
    There is a noticeable decrease in publications centered on conventional heart failure medications, as newer classes of drugs and combination therapies gain attention.
  2. Basic Science Research:
    The journal has shifted its focus away from fundamental biological mechanisms of heart failure towards more clinical applications, reducing the prevalence of basic science studies in recent issues.
  3. Single-Modal Imaging Techniques:
    As multimodal and advanced imaging approaches gain traction, traditional single-modal imaging studies, such as those focusing solely on echocardiography, are becoming less frequent.
  4. Generalized Population Studies:
    Research addressing heart failure in the general population seems to be waning, with a stronger emphasis now on specific cohorts and high-risk groups.

Similar Journals

CARDIOLOGY CLINICS

Elevating the discourse on cardiovascular health worldwide.
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0733-8651Frequency: 4 issues/year

CARDIOLOGY CLINICS is a prestigious journal published by W B SAUNDERS CO-ELSEVIER INC, offering insightful and comprehensive reviews in the field of cardiology and cardiovascular medicine since its inception in 1983. With its ISSN 0733-8651 and E-ISSN 1558-2264, the journal has established a significant impact factor within the academic community, holding a Q2 ranking in both Cardiology and Cardiovascular Medicine as well as in Medicine (miscellaneous) for 2023. Located in the heart of Philadelphia, USA, it serves as a vital resource for researchers, clinicians, and students seeking to deepen their understanding of cardiovascular diseases and advancements in treatment. Although it operates under a traditional subscription model, the journal remains committed to disseminating valuable knowledge that shapes current practices and informs future research directions. As it converges towards its 2024 issues, CARDIOLOGY CLINICS continues to play an influential role in enhancing the discourse on cardiovascular health worldwide, ensuring that its audience stays at the forefront of clinical and scientific developments.

Journal of Cardiology

Pioneering research to transform cardiology practices.
Publisher: ELSEVIERISSN: 0914-5087Frequency: 12 issues/year

Journal of Cardiology, published by ELSEVIER, stands as a prominent resource in the field of cardiology and cardiovascular medicine. With a rich history since its inception in 1987, this peer-reviewed journal aims to disseminate cutting-edge research that enhances the understanding and treatment of cardiovascular diseases. Its 2023 ranking places it in the Q2 category within its discipline, reflecting its significance and impact, as evidenced by a Scopus rank of #123 out of 387 journals, positioning it in the 68th percentile of its field. The journal is headquartered in Japan, providing a unique perspective on cardiological advances relevant not only to the Asian continent but also globally. Though it does not currently offer open access, the Journal of Cardiology remains a vital institutional resource for researchers, clinicians, and students seeking to push the boundaries of cardiovascular science and improve patient outcomes.

Anatolian Journal of Cardiology

Bridging Knowledge Gaps in Cardiology for a Healthier Tomorrow.
Publisher: KARE PUBLISSN: 2149-2263Frequency: 12 issues/year

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.

Indian Heart Journal

Unveiling the Future of Heart Health Research
Publisher: ELSEVIERISSN: 0019-4832Frequency: 6 issues/year

Indian Heart Journal, published by Elsevier, is a distinguished peer-reviewed journal dedicated to the field of cardiology and cardiovascular medicine. Founded in 1961, this journal has been a pivotal resource for researchers, healthcare professionals, and students, providing a platform for innovative studies and insights into heart health. The journal transitioned to an Open Access model in 2013, ensuring widespread dissemination of vital research findings to enhance global understanding of cardiovascular diseases. Ranked in the Q3 category for Cardiology and Cardiovascular Medicine in 2023, it holds a reputable position in the medical community, with a Scopus rank of #222 out of 387 journals in the same field, placing it in the 42nd percentile. The Indian Heart Journal strives to foster advances in clinical practice and research while addressing the unique cardiac health challenges faced in India and beyond.

HEART FAILURE REVIEWS

Transforming Heart Failure Understanding Through Collaboration
Publisher: SPRINGERISSN: 1382-4147Frequency: 6 issues/year

HEART FAILURE REVIEWS is a premier academic journal published by Springer, dedicated to the dynamic field of cardiology and cardiovascular medicine. With an impressive Q1 ranking in 2023, the journal stands as a vital resource for researchers, clinicians, and students seeking to stay abreast of the latest developments in heart failure management and research. Covering a broad spectrum of topics, including innovative therapies, epidemiology, and pathophysiology of heart failure, it fosters an environment for interdisciplinary collaboration. The journal is indexed with an ISSN of 1382-4147 and an E-ISSN of 1573-7322, ensuring widespread dissemination of knowledge. Although it does not currently offer open access options, its rigorous peer-review process guarantees high-quality content that contributes significantly to the scientific community. Established in 1996 and running through 2024, HEART FAILURE REVIEWS continues to be a leading platform for advancing understanding and treatment of heart conditions, making it an indispensable resource for all stakeholders in cardiac health.

Aktuelle Kardiologie

Shaping the future of cardiovascular care through rigorous research.
Publisher: GEORG THIEME VERLAG KGISSN: 2193-5203Frequency: 6 issues/year

Aktuelle Kardiologie is a premier journal in the field of cardiology, published by GEORG THIEME VERLAG KG. With its ISSN 2193-5203 and E-ISSN 2193-5211, it serves as an essential resource for cardiologists, researchers, and healthcare professionals who seek to stay abreast of the latest developments in cardiovascular medicine. Although currently not open access, the journal provides comprehensive insights through its rigorous peer-review process, ensuring high-quality content for its readers. Located in Stuttgart, Germany, the journal’s objectives include fostering the exchange of innovative research, clinical findings, and expert opinions that can significantly enhance patient care and inspire further studies in cardiovascular health. In an era where cardiovascular diseases are a leading public health concern, Aktuelle Kardiologie remains a vital platform for disseminating critical knowledge and advancing the field.

Archives of Cardiovascular Diseases

Pioneering research and collaboration in cardiology.
Publisher: ELSEVIER MASSON, CORP OFFISSN: 1875-2136Frequency: 12 issues/year

The Archives of Cardiovascular Diseases, published by Elsevier Masson, stands as a leading journal in the field of cardiology and cardiovascular medicine, with an impressive impact factor that underscores its relevance and influence. This esteemed journal, recognized in the Q2 category for both cardiology and miscellaneous medicine, aims to disseminate groundbreaking research, innovative methodologies, and clinical advancements that can shape the future of cardiovascular health. With its diverse array of open access options, researchers and students alike have the ability to engage with high-quality content, ensuring that cutting-edge findings are accessible globally. Since its inception in 2008, the journal has actively contributed to the advancement of knowledge in cardiovascular diseases, fostering collaboration among clinicians, researchers, and educators. Headquartered in Paris, France, Archives of Cardiovascular Diseases remains committed to enhancing our understanding of cardiovascular health and improving patient outcomes worldwide.

CANADIAN JOURNAL OF CARDIOLOGY

Connecting Clinicians and Researchers for a Healthier Heart
Publisher: ELSEVIER SCIENCE INCISSN: 0828-282XFrequency: 12 issues/year

Canadian Journal of Cardiology (ISSN: 0828-282X, E-ISSN: 1916-7075), published by Elsevier Science Inc, serves as a vital platform for disseminating high-quality research in the dynamic field of cardiology and cardiovascular medicine. Since its inception in 1985, this journal has established itself as a leader in the field, currently holding a prestigious Q1 ranking in Cardiology, indicating its significant impact and contribution to medical science. With a Scopus rank of #50 out of 387 in its category and placing in the 87th percentile, the journal showcases rigorous peer-reviewed articles that advance knowledge and practice in cardiology. Although the journal is not open access, it provides valuable insights and research findings that cater to clinicians, researchers, and students who are committed to improving cardiovascular health. As we approach the convergence of years to 2024, the Canadian Journal of Cardiology continues to strive for excellence, facilitating a discourse vital for both academic and clinical advancements in cardiology.

Kardiologia Polska

Your Gateway to Cutting-Edge Cardiac Research
Publisher: POLISH CARDIAC SOCISSN: 0022-9032Frequency: 12 issues/year

Kardiologia Polska, the esteemed journal of the Polish Cardiac Society, has established itself as a vital resource in the field of cardiology and cardiovascular medicine since its inception in 1954. With an ISSN of 0022-9032 and an E-ISSN of 1897-4279, this journal serves as a platform for groundbreaking research and scholarly articles that contribute to the advancement of heart health. Although currently not an open access journal, it remains an essential reference for practitioners and researchers seeking to stay abreast of the latest developments in cardiovascular science. The journal reflects its scholarly depth through a Category Quartile of Q3 and a commendable Scopus ranking at the 48th percentile in its field. Published primarily in Poland, it caters to a global audience eager to explore comprehensive studies spanning clinical cardiology, innovative therapeutic approaches, and emerging cardiovascular trends. Join a thriving academic community by engaging with the invaluable insights and research contributions found within the pages of Kardiologia Polska.

Cardiac Failure Review

Fostering discussions that shape cardiac care.
Publisher: RADCLIFFE CARDIOLOGYISSN: 2057-7540Frequency: 1 issue/year

Cardiac Failure Review, published by Radcliffe Cardiology, is a leading open-access journal dedicated to advancing the understanding and management of cardiac failure. With an ISSN of 2057-7540 and an E-ISSN of 2057-7559, this journal has gained significant recognition in the field, achieving a Q1 ranking in Cardiology and Cardiovascular Medicine as of 2023. Its impressive positioning at rank #97 out of 387 in Scopus further highlights its impact, placing it within the top 25th percentile of its category. Since transitioning to open access in 2019, Cardiac Failure Review has become increasingly accessible, ensuring that critical research findings are available to a global audience. The journal's focus spans innovative treatments, emerging technologies, and comprehensive reviews, effectively meeting the needs of researchers, clinicians, and students alike. With a commitment to excellence in cardiovascular medicine, Cardiac Failure Review plays a vital role in disseminating knowledge and fostering discussions that drive the field forward.